Professor Gavin Halbert
Emeritus Professor
Strathclyde Institute of Pharmacy and Biomedical Sciences
Personal statement
I obtained a pharmacy degree from the University of Strathclyde in 1979 followed by a PhD in Physiochemical Aspects of Anti-Cancer Drug Targeting Systems in 1984. I worked during pre-registration in industrial and hospital pharmacy settings, joined SIPBS as a lecturer in 1984 and was appointed Director of the Formulation Unit in 1992. The Unit's role is to characterise, analyse, formulate and manufacture putative anti-cancer drugs accepted by CRUK's New Agents Committee for use in human clinical trials, where I have now been pharmaceutically responsible for over 20 novel NCE's. Arising from this are research interests, which include medicinal and analytical chemistry, drug physiochemistry, formulation for both small volume and parenteral and oral products and the GMP production of specialist pharmaceutical products for phase l clinical trials. The latter incorporates research areas such as microbiology and lyophilisation. In addition related research is conducted in drug targeting and delivery systems for cancer chemotherapy for example the utilisation of synthetic Low Density Lipoprotein systems. I have over £10 million in personal career grant income and over 150 published papers, conference abstracts and presentations.
Undergraduate teaching is limited due to the nature of the Formulation Unit's activities to introductory and specialist courses associated with the areas above applicable to undergraduate pharmacists. Since 1987 I have been involved in post qualification education teaching for the pharmaceutical industry and initiated and teach on the joint SIPBS-David Begg Associates Qualified Persons training course which has been running since 1991.
Prize And Awards
- Fellow of Royal Society of Chemistry
- Recipient
- 5/3/2024
- Fellow of the Royal Pharmaceutical Society (FRPS)
- Recipient
- 2024
- OBE (Officer of the Most Excellent Order of the British Empire)
- Recipient
- 2024
Publications
- Assessment of biophysical properties of the first-in-class anti-cancer IgE antibody drug, MOv18 IgE demonstrates monomeric purity and stability
- Considine Paul, Punnabhum Panida, Davidson Callum G, Armstrong Georgina B, Kreiner Michaela, Bax Heather J, Chauhan Jitesh, Spicer James, Josephs Debra H, Karagiannis Sophia N, Halbert Gavin, Rattray Zahra
- mAbs Vol 17 (2025)
- https://doi.org/10.1080/19420862.2025.2512211
- Quality by digital design to accelerate sustainable medicines development
- Mustoe Chantal L, Turner Alice J, Urwin Stephanie J, Houson Ian, Feilden Helen, Markl Daniel, Al Qaraghuli Mohammed M, Chong Magdalene WS, Robertson Murray, Nordon Alison, Johnston Blair F, Brown Cameron J, Robertson John, Adjiman Claire, Batchelor Hannah, Benyahia Brahim, Bresciani Massimo, Burcham Christopher L, Cardona Javier, Cottini Ciro, Dunn Andrew S, Fradet David, Halbert Gavin W, Henson Mark, Hidber Pirmin, Langston Marianne, Lee Ye Seol, Li Wei, Mantanus Jérôme, McGinty John, Mehta Bhavik, Naz Tabbasum, Ottoboni Sara, Prasad Elke, Quist Per-Ola, Reynolds Gavin K, Rielly Chris, Rowland Martin, Schlindwein Walkiria, Schroeder Sven LM, Sefcik Jan, Settanni Ettore, Siddique Humera, Smith Kenneth, Smith Rachel, Srai Jagjit Singh, Thorat Alpana A, Vassileiou Antony, Florence Alastair J
- International Journal of Pharmaceutics Vol 681 (2025)
- https://doi.org/10.1016/j.ijpharm.2025.125625
- Investigation of aerosol jet printing for the preparation of solid dosage forms
- Turner Alice J, Prasad Elke, Florence Alastair J, Halbert Gavin W
- International Journal of Pharmaceutics Vol 671 (2025)
- https://doi.org/10.1016/j.ijpharm.2025.125288
- Probing the interplay between drug saturation, processing temperature and microstructure of amorphous solid dispersions with synchrotron X-ray phase-contrast tomography
- Bordos Ecaterina, Das Gunjan, Schroeder Sven LM, Florence Alastair, Halbert Gavin W, Robertson John
- International Journal of Pharmaceutics Vol 669 (2025)
- https://doi.org/10.1016/j.ijpharm.2024.125018
- Characterisation of colloidal structures and their solubilising potential for BCS class II drugs in fasted state simulated intestinal fluid
- McKinnon Zoe, Khadra Ibrahim, Halbert Gavin W, Batchelor Hannah K
- International Journal of Pharmaceutics Vol 665 (2024)
- https://doi.org/10.1016/j.ijpharm.2024.124733
- The aggregation properties of a therapeutic IgE
- Considine Paul, Punnabhum Panida, Davidson Callum G, Kreiner Michaela, Halbert Gavin, Rattray Zahra
- JPAG Pharmaceutical Analysis Research Awards and Careers Fair 2024 (2024)
Professional Activities
- Opening up the pharmaceutical formulation space for Additive Manufacturing
- Contributor
- 6/10/2021
- ToF-SIMS imaging of amorphous solid dispersions: a stability study
- Contributor
- 23/10/2019
- 3D imaging of controlled-release electrospun material
- Contributor
- 12/9/2017
- ToF-SIMS imaging of pharmaceutical samples: case-studies
- Contributor
- 30/11/2016
- Cencer Research UK (External organisation)
- Member
- 2011
- Invited talk at BPC September 2009
- Invited speaker
- 2009
Projects
- DHSC The Future Manufacturing Vaccine Hub: Accelerating the manufacture and deployment of cost effective vaccines
- Perrie, Yvonne (Principal Investigator) Halbert, Gavin (Co-investigator)
- 01-Jan-2023 - 28-Jan-2028
- KTP - Target Healthcare Limited. Development of platform capability and creation of a robust framework for the assessment of shelf life and stability of a range of aseptically prepared Monoclonal Anti-Bodies (MABs) for patient use.
- Perrie, Yvonne (Principal Investigator) Halbert, Gavin (Co-investigator)
- 24-Jan-2022 - 23-Jan-2024
- Royal Society of Chemistry: Developing an analytical toolbox for modelling antibody aggregation
- Rattray, Zahra (Principal Investigator) Halbert, Gavin (Principal Investigator) Considine, Paul (Post Grad Student)
- Summer internship funded by Royal Society of Chemistry- £2600
- 13-Jan-2022 - 12-Jan-2022
- Multiscale Metrology Suite for Next-generation Healthcare Technologies (EPSRC Strategic Equipment)
- Rattray, Zahra (Principal Investigator) Bruns, Nico (Co-investigator) Faulds, Karen (Co-investigator) Graham, Duncan (Co-investigator) Halbert, Gavin (Co-investigator) Hoskins, Clare (Co-investigator) McArthur, Stephen (Co-investigator) Perrie, Yvonne (Co-investigator) Reid, Stuart (Co-investigator) Seib, Philipp (Co-investigator)
- 01-Jan-2021 - 31-Jan-2024
- Doctoral Training Partnership 2020-2021 University of Strathclyde | Ferguson-Ugorenko, Agata
- Perrie, Yvonne (Principal Investigator) Halbert, Gavin (Co-investigator) Ferguson-Ugorenko, Agata (Research Co-investigator)
- 01-Jan-2021 - 01-Jan-2025
- Development of a first-in-class IKKalpha inhibitor for the treatment of castrate resistant p
- MacKay, Simon (Principal Investigator) Halbert, Gavin (Co-investigator) Paul, Andrew (Co-investigator) Suckling, Colin (Co-investigator) Watson, David (Co-investigator)
- 01-Jan-2020 - 31-Jan-2024
Contact
Professor
Gavin
Halbert
Emeritus Professor
Strathclyde Institute of Pharmacy and Biomedical Sciences
Email: g.w.halbert@strath.ac.uk
Tel: Unlisted